Telmisartan, ramipril, or both in patients at high risk for vascular events.
Yusuf S; Teo KK; Pogue J; Dyal L; Copland I; Schumacher H; Dagenais G; Sleight P; Anderson C; The New England Journal Of Medicine, 2008, vol. 358, issue 15, p 1547, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation